Patents by Inventor Brandon Lee Roller

Brandon Lee Roller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220287749
    Abstract: Systems for treating and/or preventing fractures include at least one needle sized and configured to be placed into target bone and at least one implantable pin configured to be releasably held in a first needle of the at least one needle. The systems also include at least one delivery device of injectable material configured to couple to the first needle while the first implantable pin is held in the first needle whereby the at least one delivery device and a respective needle cooperate to serially provide an external column of the injectable material about the at least one implantable pin.
    Type: Application
    Filed: August 27, 2020
    Publication date: September 15, 2022
    Inventors: Philip Jayson Brown, Brandon Lee Roller
  • Patent number: 9733257
    Abstract: Biomarkers, biomarker panels and methods for diagnosing osteoarthritis (OA) and determining treatment are disclosed, using measurement of the expression level of certain polypeptides in a test sample from a subject, including MCP1, IL8, KC, MMP2, MMP3, Apolipoprotein A1, and Apolipoprotein E. Related methods for monitoring OA treatment efficacy, diagnostic reagents, and kits are also described.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: August 15, 2017
    Inventors: James L. Cook, Cristi R. Cook, Aaron M. Stoker, Keiichi Kuroki, Bridget Colleen Garner, Richard Evans, Brandon Lee Roller, Prakash Sidha Jayabalan
  • Publication number: 20170030925
    Abstract: Biomarkers, biomarker panels and methods for diagnosing osteoarthritis (OA) and determining treatment are disclosed, using measurement of the expression level of certain polypeptides in a test sample from a subject, including MCP1, IL8, KC, MMP2, MMP3, Apolipoprotein A1, and Apolipoprotein E. Related methods for monitoring OA treatment efficacy, diagnostic reagents, and kits are also described.
    Type: Application
    Filed: October 11, 2016
    Publication date: February 2, 2017
    Inventors: James L. Cook, Cristi R. Cook, Aaron M. Stoker, Keiichi Kuroki, Bridget Colleen Garner, Richard Evans, Brandon Lee Roller, Prakash Sidha Jayabalan
  • Patent number: 9488646
    Abstract: Biomarkers, biomarker panels and methods for diagnosing osteoarthritis (OA) and determining treatment are disclosed, using measurement of the expression level of certain polypeptides in a test sample from a subject, including MCP1, IL8, KC, MMP2, MMP3, Apolipoprotein A1, and Apolipoprotein E. Related methods for monitoring OA treatment efficacy, diagnostic reagents, and kits are also described.
    Type: Grant
    Filed: February 7, 2014
    Date of Patent: November 8, 2016
    Assignee: The Curators of the University of Missouri
    Inventors: James L. Cook, Cristi R. Cook, Aaron M. Stoker, Keiichi Kuroki, Bridget Colleen Garner, Richard Evans, Brandon Lee Roller, Prakash Sidha Jayabalan
  • Publication number: 20140155499
    Abstract: Biomarkers, biomarker panels and methods for diagnosing osteoarthritis (OA) and determining treatment are disclosed, using measurement of the expression level of certain polypeptides in a test sample from a subject, including MCP1, IL8, KC, MMP2, MMP3, Apolipoprotein A1, and Apolipoprotein E. Related methods for monitoring OA treatment efficacy, diagnostic reagents, and kits are also described.
    Type: Application
    Filed: February 7, 2014
    Publication date: June 5, 2014
    Inventors: James L. Cook, Cristi R. Cook, Aaron M. Stoker, Keiichi Kuroki, Bridget Colleen Garner, Richard Evans, Brandon Lee Roller, Prakash Sidha Jayabalan
  • Publication number: 20110218116
    Abstract: Biomarkers, biomarker panels and methods for diagnosing osteoarthritis (OA) are disclosed, using measurement of the expression level of certain polypeptides in a test sample from a subject, including MCP1, IL8, KC, MMP2, MMP3, IL6, MMP1, RANTES, MMP9, IL1B, Apolipoprotein A1, Apolipoprotein E, DCN, CILP and COMP. Related methods for monitoring OA treatment efficacy, diagnostic reagents, and kits are also described.
    Type: Application
    Filed: March 4, 2011
    Publication date: September 8, 2011
    Applicant: THE CURATORS OF THE UNIVERSITY OF MISSOURI
    Inventors: James L. Cook, Cristi R. Cook, Aaron M. Stoker, Keiichi Kuroki, Bridget Colleen Garner, Richard Evans, Brandon Lee Roller, Prakash Sidha Jayabalan